{
  "retracted": false,
  "timestamp": 1585699200000,
  "updates": [
    {
      "timestamp": 1591774368726,
      "identifier": {
        "doi": "10.1038/s41467-020-15532-1"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41467-019-11782-w"
  },
  "journal": "Nature Communications",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control"
}
